Unknown

Dataset Information

Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis.


ABSTRACT:

Background

B cell immune dysregulation plays a critical role in myasthenia gravis (MG). However, targeted B-cell therapy such as rituximab may result in long-term peripheral B cell clearance and allow for the survival of plasma cells, contributing to frequent infections and relapses. Therefore, we aimed to identify potential novel therapeutic targets that preserve part of B cell function while inhibiting antibody-secreting cells (ASCs).

Methods

The transcriptome of sorted CD19+B cells obtained from MG patients in active and remission state was performed by RNA sequencing. The hallmark gene NF-kappaB-inducing kinase (NIK/MAP3K14) associated with NF-κB and TNF signaling was identified, and the expression levels of NIK in CD19+B cells, CD4+T cel

SUBMITTER: Huang X 

PROVIDER: S-EPMC11759451 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature